1. Interprofessional Approach to Managing Adverse Events of PI3K Inhibitors

3. Approved PI3K Inhibitors

4. PI3K Isoforms and Inhibitors

5. Common AEs With PI3K Inhibitors

6. Possible Reasons for Drug-Specific AEs

7. Black Box Warnings With PI3K Inhibitors

8. Overview of Healthcare Team Model

9. Case 1

10. Case 1: Educating the Patient

11. Case 1 (cont)

12. Case 1: Notes on Diarrhea

13. Case 1: Management of Diarrhea

14. Case 1: Pearls on Team Management of Diarrhea

15. Case 1: Wrap-Up and Discussion

16. Case 2

17. Case 2: Copanlisib vs Other PI3K Inhibitors

18. Case 2: Notes on Hyperglycemia

19. Case 2: Notes on Hyperglycemia (cont)

20. Case 2: Team-Based Monitoring and Diagnosis

21. Case 2: Management of Hyperglycemia

22. Case 2: Pearls on Managing Hyperglycemia

23. Case 2: Wrap-Up and Discussion

24. Case 3

25. Case 3: Risk of Infection

26. Case 3: Drug-Drug Interactions

27. Case 3 (cont)

28. Case 3: Notes on Pneumonia and Pneumonitis

29. Case 3: Management of Infectious Pneumonia

30. Pneumonitis vs Viral Infection

31. Sum-Up: General Principles of Management

32. Sum-Up: Pearls for Team-Based Care

33. Abbreviations